A NOVEL CYTOKINE-ANTIBODY FUSION PROTEIN, N-820, TO ENHANCE THE FUNCTIONS OF EX-VIVO EXPANDED NATURAL KILLER CELLS AGAINST BURKITT LYMPHOMA. (October 2022)